Company Valuation: Abpro Bio Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 75,465 142,117 461,443 244,023 115,496 155,155
Change - 88.32% 224.69% -47.12% -52.67% 34.34%
Enterprise Value (EV) 1 114,038 171,895 441,953 211,443 104,603 147,080
Change - 50.73% 157.11% -52.16% -50.53% 40.61%
P/E ratio -5.63x -2.94x -6.28x -22.3x -13.9x -5.89x
PBR 0.72x 1.1x 3.32x 1.83x 0.82x 1.27x
PEG - -0x -0.92x 0.3x 0.5x -0x
Capitalization / Revenue 1.28x 4.45x 9.36x 7.41x 5.22x 6.11x
EV / Revenue 1.94x 5.38x 8.97x 6.42x 4.73x 5.8x
EV / EBITDA 7,775x -6.69x -556x -78.1x -10.7x -17.7x
EV / EBIT -19.1x -5.7x -55x -39.6x -9.35x -14.5x
EV / FCF -47.8x -7.42x 33.4x -16.6x -15.6x -21.9x
FCF Yield -2.09% -13.5% 2.99% -6.02% -6.42% -4.56%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -139 -273.4 -292.1 -43.31 -30.36 -92.51
Distribution rate - - - - - -
Net sales 1 58,911 31,930 49,282 32,914 22,112 25,375
EBITDA 1 14.67 -25,686 -794.6 -2,708 -9,791 -8,305
EBIT 1 -5,985 -30,149 -8,043 -5,333 -11,193 -10,175
Net income 1 -11,058 -35,694 -58,972 -10,030 -8,145 -25,742
Net Debt 1 38,573 29,778 -19,491 -32,581 -10,893 -8,075
Reference price 2 783.00 804.00 1,835.00 965.00 422.00 545.00
Nbr of stocks (in thousands) 96,379 176,762 251,468 252,874 273,688 284,688
Announcement Date 3/19/19 3/13/20 3/22/21 3/31/22 3/23/23 3/21/24
1KRW in Million2KRW
Estimates

Add to a list
P/E ratio (Y) EV / Sales (Y) EV / EBITDA (Y) Yield (Y) Capi.($)
35.93x0.71x5.4x4.21% 2.27B
17.57x1.08x9.61x1.51% 1.83B
17.41x1.02x6.67x1.2% 1.8B
20.15x1.13x7.68x3.56% 1.74B
25.38x - - - 1.54B
19.38x3.05x14.15x1.92% 1.5B
Average 22.63x 1.40x 8.70x percentage-no-prefix 1.78B
Weighted average by Cap. 23.23x 1.31x 8.37x percentage-no-prefix
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A195990 Stock
  4. Valuation Abpro Bio Co., Ltd.